The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A cardiologist shares insights on the findings.

South Korea offers two live zoster vaccines — SkyZoster was approved in 2017 and Zostavax in 2009. The US allowed Zostavax until 2020.. Researchers found that its effectiveness waned over time ...

Shingles vaccine may cut heart disease risk, new study finds 03:48. Getting a shingles vaccine may help with more than the viral infection that causes painful rashes — new research shows it can ...

The study is different in a major way. Previous research has shown a link between the shingles vaccine and dementia — for example, a 2024 study by the University of Oxford found that the newer ...

A novel approach in vaccine research offers hope for overcoming challenges in developing an effective Hepatitis C vaccine, targeting viral diversity and immune evasion.

Receipt of zoster vaccine reduced the probability of a new dementia diagnosis during a 7-year follow-up period by 3.5 percentage points, corresponding to a relative reduction of 20.0%.